$64.06
1.40[2.23%]
At close: Apr 26
$64.06
0[0.00%]
After Hours: 4:20PM EDT
Bio-Techne: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Mar 11, 2024 | Roeland Nusse | DIRECTOR | -10.4K | $76.98 | -$800.63K | SELL | -19.44% | 43.097K | Mar 07 | View |
Sep 01, 2023 | Roeland Nusse | DIRECTOR | 23.061K | $51.36 | -$1.16K | SELL-OPTIONS | 80.04% | 51.872K | Aug 30 | View |
Jul 25, 2023 | Charles Kummeth | CHIEF EXECUTIVE OFFICER | -80K | $88.36 | -$7.07M | SELL | -5.97% | 1.259166M | Jul 21 | View |
Jun 09, 2023 | Charles Kummeth | CHIEF EXECUTIVE OFFICER | -322 | $83.00 | -$26.73K | SELL | -0.03% | 1.113217M | Jun 07 | View |
Dec 09, 2022 | Brenda S Furlow | SVP - GENERAL COUNSEL | 0 | $56.69 | -$419.50K | SELL-OPTIONS | 0.00% | 31.412K | Dec 07 - Dec 08 | View |
Aug 12, 2022 | JOHN HIGGINS | DIRECTOR | 896 | $222.85 | -$721.06K | SELL-OPTIONS | 19.45% | 5.502K | Aug 10 - Aug 11 | View |
Jun 09, 2022 | JOHN HIGGINS | 0 | $215.94 | -$476.92K | SELL-OPTIONS | 0.00% | 4.606K | Jun 07 - Jun 08 | View | |
Jun 09, 2022 | Charles Kummeth | CHIEF EXECUTIVE OFFICER | 0 | $236.75 | -$1.31M | SELL-OPTIONS | 0.00% | 198.438K | Jun 07 | View |
May 11, 2022 | Robert V Baumgartner | 300 | $352.55 | $105.77K | BUY | 3.06% | 10.106K | May 10 | View | |
Nov 23, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | 0 | $328.08 | -$177.30K | SELL-OPTIONS | 0.00% | 0 | Nov 19 | View |
Nov 16, 2021 | N. David Eansor pursuant to Power of Attorney previously filed. | PRESIDENT-PROTEIN SCIENCES | 799 | $314.53 | -$10.19M | SELL-OPTIONS | 60.62% | 2.117K | Nov 12 - Nov 16 | View |
Nov 03, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0 | $325.77 | -$3.62M | SELL-OPTIONS | 0.00% | 10.755K | Nov 01 - Nov 02 | View |
Nov 01, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | -100 | $325.14 | -$317.44K | SELL | -0.92% | 10.755K | Oct 28 - Oct 29 | View |
Sep 24, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | -822 | $529.04 | -$434.87K | SELL | -100.00% | 0 | Sep 22 | View |
Sep 09, 2021 | Randolph C Steer | DIRECTOR | 0 | $299.78 | -$3.36M | SELL-OPTIONS | 0.00% | 5.112K | Sep 07 | View |
Sep 07, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0 | $306.90 | -$4.01M | SELL-OPTIONS | 0.00% | 10.855K | Sep 02 | View |
Sep 07, 2021 | Brenda S Furlow | SVP - GENERAL COUNSEL | 0 | $317.49 | -$2.64M | SELL-OPTIONS | 0.00% | 7.62K | Sep 02 | View |
Sep 02, 2021 | N. David Eansor pursuant to Power of Attorney previously filed. | PRESIDENT-PROTEIN SCIENCES | -1.538K | $503.07 | -$773.73K | SELL | -53.85% | 1.318K | Aug 31 | View |
Sep 02, 2021 | Brenda S Furlow | SVP - GENERAL COUNSEL | 0 | $315.36 | -$1.90M | SELL-OPTIONS | 0.00% | 7.62K | Aug 31 | View |
Browse insider trades on all stocks.